1,25-Dihydroxyvitamin D3 stimulates the production of insulin-like growth factor-binding proteins-2, -3 and -4 in human bone marrow stromal cells

European Journal of Endocrinology

Volumn 144, Issue 5, 2001, Pages 549-557

  Kveiborg, M ^a,b   Flyvbjerg, A ^c   Eriksen, E F ^a   Kassem, M ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Institute of Experimental Clinical Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NORMAL HUMAN; NORTHERN BLOTTING; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; WESTERN BLOTTING;

EID: 0035016820     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440549     Document Type: Article

References (50)

1. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K. Yoshihara Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics 1997 16 391-396.
2. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research 1998 13 325-549.
3. Beresford JN, Gallagher JA & Russell RG. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology 1986 119 1776-1785.
4. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. Journal of Cellular Physiology 1990 143 420-430.
5. Hedlund TE, Moffatt KA & Miller GJ. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996 137 1554-1561.
6. Ryhanen S, Jaaskelainen T, Saarela JT & Maenpaa PH. Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093). Journal of Cellular Biochemistry 1998 70 414-424.
7. Wergedal JE, Mohan S, Lundy M & Baylink DJ. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. Journal of Bone and Mineral Research 1990 5 179-186.
8. Hock JM, Centrella M & Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988 122 254-260.
9. Murphy LJ. Insulin-like growth factor-binding proteins: functional diversity or redundancy? Journal of Molecular Endocrinology 1998 21 97-107.
10. Kanzaki S, Hilliker S, Baylink DJ & Mohan S. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 1994 134 383-392.
11. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. PNAS 1999 96 3149-3153.
12. Moriwake T, Tanaka H, Kanzaki S, Higuchi J & Seino Y. 1,25-Dihydroxyvitamin D3 stimulates the secretion of insulin-like growth factor binding protein 3 (IGFBP-3) by cultured human osteosarcoma cells. Endocrinology 1992 130 1071-1073.
13. Scharla SH, Strong DD, Rosen C, Mohan S, Holick M, Baylink DJ et al. 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo. Journal of Clinical Endocrinology and Metabolism 1993 77 1190-1197.
14. Okazaki R, Riggs BL & Conover CA. Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 1994 134 126-132.
15. Kassem M, Okazaki R, De Leon D, Harris SA, Robinson JA, Spelsberg TC et al. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. Proceedings of the Association of American Physicians 1996 108 155-164.
16. Cheng SL, Zhang SF, Mohan S, Lecanda F, Fausto A, Hunt AH et al. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. Journal of Cellular Biochemistry 1998 71 449-458.
17. Mohan S & Baylink DJ. Characterization of the ICF regulatory system in bone. Advances in Experimental Medicine and Biology 1993 343 397-406.
18. Chenu C, Valentin-Opran A, Chavassieux P, Saez S, Meunier PJ & Delmas PD. Insulin like growth factor 1 hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. Bone 1990 11 81-86.
19. Kassem M, Risteli L, Mosekilde L, Melsen F & Eriksen EF. Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS 1991 99 269-274.
20. Haynesworth SE, Goshima J, Goldberg VM & Caplan Al. Characterization of cells with osteogenic potential from human marrow. Bone 1992 13 81-88.
21. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC & Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. Journal of Bone and Mineral Research 1996 11 312-324.
22. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B & Caplan Al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. Journal of Bone and Mineral Research 1999 14 700-709.
23. Beresford JN, Joyner CJ, Devlin C & Triffitt JT. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Archives of Oral Biology 1994 39 941-947.
24. Liu P, Oyajobi BO, Russell RG & Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) in vitro. Calcified Tissue International 1999 65 173-180.
25. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993 15 532-534536-537.
26. Lamson G, Giudice LC & Rosenfeld RG. A simple assay for proteolysis of IGFBP-3. Journal of Clinical Endocrinology and Metabolism 1991 72 1391-1393.
27. Conover CA, Kiefer MC & Zapf J. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. Journal of Clinical Investigation 1993 91 1129-1137.
28. Kassem M, Blum W, Ristelli J, Mosekilde L & Eriksen EF. Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcified Tissue International 1993 52 222-226.
29. Hassager C, Fitzpatrick LA, Spencer EM, Riggs BL & Conover CA. Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. Journal of Clinical Endocrinology and Metabolism 1992 75 228-233.
30. Okazaki R, Conover CA, Harris SA, Spelsberg TC & Riggs BL. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. Journal of Bone and Mineral Research 1995 10 788-795.
31. Thomas T, Gori F, Spelsberg TC, Khosla S, Riggs BL & Conover CA. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 1999 140 5036-5044.
32. Birnbaum RS & Wiren KM. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 1994 135 223-230.
33. Thrailkill KM, Siddhanti SR, Fowlkes JL & Quarles LD. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of ICF-I and IGFBPs. Bone 1995 17 307-313.
34. McCarthy TL, Centrella M & Canalis E. Constitutive synthesis of insulin-like growth factor-II by primary osteoblast-enriched cultures from fetal rat calvariae. Endocrinology 1992 130 1303-1308.
35. Bang P, Baxter RC, Blum WF, Breier BH, Clemmons DR, Hall K et al. Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors. Journal of Endocrinology 1994 143 C1-C2.
36. Scharla SH, Strong DD, Mohan S, Baylink DJ & Linkhart TA. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 1991 129 3139-3146.
37. Linkhart TA & Keffer MJ. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1.25-dihydroxyvitamin D3. Endocrinology 1991 128 1511-1518.
38. Nakao Y, Hilliker S, Baylink DJ & Mohan S. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro. Journal of Bone and Mineral Research 1994 9 865-872.
39. Torring O, Firek AF, Heath Hd & Conover CA. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through an adenosine 3′,5′-monophosphate-dependent mechanism. Endocrinology 1991 128 1006-1014.
40. Gao L, Ling N & Shimasaki S. Structure of the rat insulin-like growth factor binding protein-4 gene. Biochemical and Biophysical Research Communications 1993 190 1053-1059.
41. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB & Bierich JR. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 1989 125 766-772.
42. Ramagnolo D, Akers RM, Byatt JC, Wong EA & Turner JD. IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells. Molecular and Cellular Endocrinology 1994 102 131-139.
43. Schmid C, Rutishauser J, Schlapfer I, Froesch ER & Zapf J. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF 1-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochemical and Biophysical Research Communications 1991 179 579-585.
44. Gustafsson T, Andersson P & Arnqvist HJ. Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. Journal of Endocrinology 1999 161 245-253.
45. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C et al. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. Journal of Biological Chemistry 1995 270 20424-20431.
46. Bourner MJ, Busby WH Jr, Siegel NR, Krivi GG, McCusker RH & Clemmons DR. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. Journal of Cellular Biochemistry 1992 48 215-226.
47. Feyen JH, Evans DB, Binkert C, Heinrich GF, Geisse S & Kocher HP. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. Journal of Biological Chemistry 1991 266 19469-19474.
48. Hoflich A, Lahm H, Blum W, Kolb H & Wolf E. Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Letters 1998 434 329-334.
49. Oh Y, Muller HL, Lamson G & Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. Journal of Biological Chemistry 1993 268 14964-14971.
50. Rajah R, Valentinis B & Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53-and IGF-independent mechanism. Journal of Biological Chemistry 1997 272 12181-12188.